Loading publications…
The last 5 uploaded publications
Use of Oral Anticoagulants in Patients with Atrial Fibrillation: Preliminary Data from the Italian Atrial Fibrillation (ITALY-AF) Registry
Fabio Angeli, Gianpaolo Reboldi, Giancarlo Agnelli, Giuseppe Ambrosio, Alessandro Capucci, Giovanni Carreras, Claudio Cavallini, Adriano Murrone, Gaetano Vaudo, Gianluca Zingarini, Paolo Verdecchia (2023). Use of Oral Anticoagulants in Patients with Atrial Fibrillation: Preliminary Data from the Italian Atrial Fibrillation (ITALY-AF) Registry. , 13(5), DOI: https://doi.org/10.3390/clinpract13050105.
Article76 days agoSafety of catheter ablation of atrial fibrillation in cancer survivors
Michela Giustozzi, Hussam Ali, Gianpaolo Reboldi, Cristina Balla, Sara Foresti, Guido De Ambroggi, Pier Paolo Lupo, Giancarlo Agnelli, Riccardo Cappato (2020). Safety of catheter ablation of atrial fibrillation in cancer survivors. , 60(3), DOI: https://doi.org/10.1007/s10840-020-00745-7.
Article76 days agoType 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients with Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study
Maria Cristina Vedovati, Gianpaolo Reboldi, Giancarlo Agnelli, Paolo Verdecchia (2019). Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients with Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study. , 03(02), DOI: https://doi.org/10.1055/s-0039-1692202.
Article76 days ago